Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-06-02T01:39:41.231Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug Utilization Review of Cholinesterase Inhibitors in Quebec

Published online by Cambridge University Press:  02 December 2014

Fadi Massoud ,
Marc Dorais ,
Claudie Charbonneau ,
Bénédicte Lescrauwaet ,
Jean-Marc Boucher  and
Jacques LeLorier
Fadi Massoud*
Affiliation:
Service de Gériatrie, Montreal, QC Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Département de Médecine, Montreal, QC
Marc Dorais
Affiliation:
Pharmacoeconomic and Pharmacoepidemiology Research Unit, Montreal, QC
Claudie Charbonneau
Affiliation:
Centre Hospitalier de l’Université de Montréal, Montreal, QC Pfizer Inc., New York, NY, USA
Bénédicte Lescrauwaet
Affiliation:
Formerly of Pfizer Canada Inc., Kirkland, Quebec
Jean-Marc Boucher
Affiliation:
Service de Gériatrie, Montreal, QC Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Département de Médecine, Montreal, QC
Jacques LeLorier
Affiliation:
Pharmacoeconomic and Pharmacoepidemiology Research Unit, Montreal, QC Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Département de Médecine, Montreal, QC
*
Hôpital Notre–Dame, Service de Gériatrie, 1560 rue Sherbrooke est,Montréal, Québec, H2L 4M1, Canada.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Peer Reviewed Letter
Information
Canadian Journal of Neurological Sciences , Volume 35 , Issue 4 , September 2008 , pp. 508 - 509
Copyright
Copyright © The Canadian Journal of Neurological 2008

References

1. Canadian study of health and aging. Study methods and prevalence of dementia. Can Med Assoc J. 1994;150:899–13.Google Scholar
2. Von Korff, M, Wagner, EH, Saunders, K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197–203.CrossRefGoogle ScholarPubMed
3. Herrmann, N, Gill, SS, Bell, CM, Anderson, GM, Bronskill, SE, Shulman, KE, et al. A population-based study of cholinesterase inhibitor use for dementia. J Am Geriatr Soci. 2007;55:1517–23.CrossRefGoogle ScholarPubMed
4. Suh, DC, Thomas, SK, Valiyeva, E, Arcona, S, Vo, L. Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer’s disease. Drugs Aging. 2005;22:695–07.CrossRefGoogle ScholarPubMed
5. Singh, G, Thomas, SK, Arcona, S, Lingala, V, Mithal, A. Treatment persistency with rivastigmine and donepezil in a large state medicaid program. J Am Ger Soc. 2005;53:1269–70.CrossRefGoogle Scholar